You are here

Treatments

Research indicates SARS-CoV-2 antibodies in kids after COVID may peak at 1 to 3 months

Wed, 2022-08-31 12:25 — mike kraft

SARS-CoV-2 antibodies in kids after COVID may peak at 1 to 3 months Neutralizing antibody levels peaked at 84% 1 to 3 months post-infection but stayed around 70% for 13 months. CIDRAP

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Read more about Research indicates SARS-CoV-2 antibodies in kids after COVID may peak at 1 to 3 months
Log in or register to post comments

Boosters: US clears updated COVID boosters targeting newest variants

Wed, 2022-08-31 10:10 — mike kraft

US clears updated COVID boosters targeting newest variants WASHINGTON (AP) — The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today’s most common omicron strain. Shots could begin within days. The move by the Food and Drug Administration tweaks the recipe of shots made by Pfizer and rival Moderna that already have saved millions of lives. AP NEWS

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Boosters: US clears updated COVID boosters targeting newest variants
Log in or register to post comments

CDC advisers to meet Thursday on Omicron-retooled boosters

Tue, 2022-08-30 17:44 — mike kraft

CDC advisers to decide on Omicron-retooled boosters on Sept 1 Advisers to the U.S. Centers for Disease Control and Prevention (CDC) will meet on Thursday to vote on whether to recommend the use of two COVID-19 vaccine boosters tailored against the Omicron variant. Reuters Reuters

...

The so-called bivalent vaccines include both the currently dominant BA.4 and BA.5 Omicron subvariants and the original version of the virus. ...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about CDC advisers to meet Thursday on Omicron-retooled boosters
Log in or register to post comments

mRNA COVID vaccines protect against severe Omicron for at least half a year--new study

Mon, 2022-08-29 17:50 — mike kraft

mRNA COVID vaccines protect against severe Omicron for at least half a year mRNA booster protection against severe COVID-19 was 87% and didn't wane for 6 months, a new study shows. CIDRAP

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about mRNA COVID vaccines protect against severe Omicron for at least half a year--new study
Log in or register to post comments

U.S. to provide $11 mln for production of monkeypox vaccine

Mon, 2022-08-29 17:20 — mike kraft

U.S. govt to provide $11 mln for production of monkeypox vaccine The U.S. government said on Monday it would provide about $11 million to support the packaging of Bavarian Nordic's Jynneos monkeypox vaccine at a U.S.-based manufacturer's facility. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. to provide $11 mln for production of monkeypox vaccine
Log in or register to post comments

Monkeypox: Officials ‘cautiously optimistic’ about falling monkeypox cases

Mon, 2022-08-29 09:08 — mike kraft

Officials ‘cautiously optimistic’ about falling monkeypox cases The worldwide monkeypox outbreak may have peaked, amid evidence that gay men are curbing risky sexual behaviors and more people are getting vaccinated Dan Diamond Washington Post

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Monkeypox: Officials ‘cautiously optimistic’ about falling monkeypox cases
Log in or register to post comments

White House effort to stave off fall COVID surge with new boosters faces uphill battle

Mon, 2022-08-29 08:33 — mike kraft

White House effort to stave off fall COVID surge with new boosters faces uphill battle The White House is rushing ahead to roll out a new COVID-19 booster shot campaign in early September, but is facing an uphill battle to ensure it is successful. The vaccines being … aneklason The Hill

...

Country / Region Tags:

General Topic Tags:

Public Attitudes

Problem, Solution, SitRep, or ?:

Situation Report

Read more about White House effort to stave off fall COVID surge with new boosters faces uphill battle
Log in or register to post comments

UK approves Novavax COVID shot for 12-17 year-olds

Fri, 2022-08-26 12:37 — mike kraft

Britain approves Novavax COVID shot for 12-17 year-olds Britain's medicines regulator on Friday approved Novavax's COVID-19 vaccine for children aged between 12 and 17 years. Reuters Reuters

...

The mRNA vaccines made by Moderna as well as the partnership between Pfizer-BioNTech are also cleared for use by this age group, the Medicines and Healthcare products Regulatory Agency (MHRA) said. ...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about UK approves Novavax COVID shot for 12-17 year-olds
Log in or register to post comments

Country- by- country report on vaccines delivered to poorer nations by international agency

Fri, 2022-08-26 09:59 — mike kraft

Factbox: Vaccines delivered under COVAX sharing scheme for poorer countries The COVAX facility, backed by the World Health Organization (WHO) and the Global Alliance for Vaccines and Immunization (GAVI), has delivered 1.63 billion COVID-19 vaccine doses to 146 countries, GAVI data shows. Reuters Reuters

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Country- by- country report on vaccines delivered to poorer nations by international agency
Log in or register to post comments

Moderna sued Pfizer and BioNTech, accusing them of copying the central technology behind its coronavirus vaccine.

Fri, 2022-08-26 09:36 — mike kraft

Moderna files patent infringement lawsuits against Pfizer and BioNTech over mRNA Covid-19 vaccines | CNN Moderna on Friday filed patent infringement lawsuits against Pfizer and BioNTech "for infringing patents central to (its) mRNA technology platform," the company said in a news release Friday. Ben Tinker,Amanda Sealy CNN

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Pages

Page loaded in 0.588 seconds.